Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Beyond static measurements: dynamic frailty improves survival prediction in multiple myeloma.
Smits F, Groen K, Levin MD, Stege C, van Kampen RJW, van der Spek E, Bilgin YM, Thielen N, Nijhof IS, Ludwig I, de Waal EGM, Sandberg Y, Kentos A, Timmers GJ, Regelink JC, Westerman M, Heer K, Vekemans MM, Durdu-Rayman N, de Graauw NCHP, Seefat MR, van de Donk NWCJ, Ypma PF, Nasserinejad K, Zweegman S. Smits F, et al. Among authors: groen k. Blood. 2024 Nov 22:blood.2024025868. doi: 10.1182/blood.2024025868. Online ahead of print. Blood. 2024. PMID: 39576961
Perspective matters in recovery: the views of persons with severe mental illness, family and mental health professionals on collaboration during recovery, a qualitative study.
Burger TJ, van Eck RM, Lachmeijer M, de Wilde-Schutten KRG, Lansen M, van Alphen C, van Haasteren N, Groen K, Schirmbeck F, Vellinga A, Kikkert MJ, Dekker J, de Haan L, de Koning MB. Burger TJ, et al. Among authors: groen k. BMC Psychiatry. 2024 Nov 14;24(1):802. doi: 10.1186/s12888-024-06198-w. BMC Psychiatry. 2024. PMID: 39543545 Free PMC article.
Prophylactic tocilizumab reduces the incidence of cytokine release syndrome in relapsed/refractory myeloma patients treated with teclistamab: Implications for outpatient step-up dosing.
Korst CLBM, Groen K, Bosman PWC, van der Valk F, Verkleij CPM, Kruyswijk S, de Ruijter MEM, Heijink DM, Kuipers MT, Zweegman S, van de Donk NWCJ. Korst CLBM, et al. Among authors: groen k. Hemasphere. 2024 Jul 24;8(7):e132. doi: 10.1002/hem3.132. eCollection 2024 Jul. Hemasphere. 2024. PMID: 39050549 Free PMC article. No abstract available.
Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies.
Fernbach S, Mair NK, Abela IA, Groen K, Kuratli R, Lork M, Thorball CW, Bernasconi E, Filippidis P, Leuzinger K, Notter J, Rauch A, Hirsch HH, Huber M, Günthard HF, Fellay J, Kouyos RD, Hale BG; Swiss HIV Cohort Study. Fernbach S, et al. Among authors: groen k. J Exp Med. 2024 Sep 2;221(9):e20240365. doi: 10.1084/jem.20240365. Epub 2024 Jul 17. J Exp Med. 2024. PMID: 39017930 Free PMC article.
Assessing frailty in myeloma: The pursuit of simplicity may sacrifice precision of predicting clinical outcomes.
Groen K, Smits F, Nasserinejad K, Levin MD, Regelink JC, Timmers GJ, de Waal EGM, Westerman M, Velders GA, de Heer K, Leys RBL, van Kampen RJW, Stege CAM, Seefat MR, Nijhof IS, van der Spek E, Klein SK, van de Donk NWCJ, Ypma PF, Zweegman S. Groen K, et al. Hemasphere. 2024 Jul 4;8(7):e85. doi: 10.1002/hem3.85. eCollection 2024 Jul. Hemasphere. 2024. PMID: 38966208 Free PMC article. No abstract available.
A new variant in the ZCCHC8 gene: diverse clinical phenotypes and expression in the lung.
Groen K, van der Vis JJ, van Batenburg AA, Kazemier KM, de Bruijn MJW, Stadhouders R, Arp P, Verkerk AJMH, Schoemaker AE, de Bie CI, Massink MPG, van Beek FT, Grutters JC, Vergouw LJM, van Moorsel CHM. Groen K, et al. ERJ Open Res. 2024 Feb 19;10(1):00487-2023. doi: 10.1183/23120541.00487-2023. eCollection 2024 Jan. ERJ Open Res. 2024. PMID: 38375433 Free PMC article.
Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation.
Frerichs KA, Verkleij CPM, Mateos MV, Martin TG, Rodriguez C, Nooka A, Banerjee A, Chastain K, Perales-Puchalt A, Stephenson T, Uhlar C, Kobos R, van der Holt B, Kruyswijk S, Kuipers MT, Groen K, Vishwamitra D, Skerget S, Cortes-Selva D, Doyle M, Zaaijer HL, Zweegman S, Verona RI, van de Donk NWCJ. Frerichs KA, et al. Among authors: groen k. Blood Adv. 2024 Jan 9;8(1):194-206. doi: 10.1182/bloodadvances.2023011658. Blood Adv. 2024. PMID: 38052042 Free PMC article.
Correctly structured problem lists lead to better and faster clinical decision-making in electronic health records compared to non-curated problem lists: A single-blinded crossover randomized controlled trial.
Klappe ES, Heijmans J, Groen K, Ter Schure J, Cornet R, de Keizer NF. Klappe ES, et al. Among authors: groen k. Int J Med Inform. 2023 Dec;180:105264. doi: 10.1016/j.ijmedinf.2023.105264. Epub 2023 Oct 19. Int J Med Inform. 2023. PMID: 37890203 Free article. Clinical Trial.
Treatment sequences and drug costs from diagnosis to death in multiple myeloma.
Seefat MR, Cucchi DGJ, Groen K, Donker ML, van der Hem KG, Westerman M, Gerrits AM, Beeker A, van de Donk NWCJ, Blommestein HM, Zweegman S. Seefat MR, et al. Among authors: groen k. Eur J Haematol. 2024 Mar;112(3):360-366. doi: 10.1111/ejh.14119. Epub 2023 Oct 11. Eur J Haematol. 2024. PMID: 37821211
86 results